| Toggle Summary
|
Peer-reviewed Publication on the use of Grafix® in High-Risk Peripheral Arterial Disease Patients with Treatment Refractory Ulcerations Demonstrating Durable Wound Closure
|
View HTML
|
| Toggle Summary
|
Osiris Provides Update Regarding NASDAQ Listing Matters
|
View HTML
|
| Toggle Summary
|
Osiris Therapeutics, Inc. Reports Preliminary 2014 and 2015 Revenue and Anticipated 2016 Revenue
|
View HTML
|
| Toggle Summary
|
Peer-reviewed Publication on the use of Grafix® Prime for Outpatient Management of Complex Wounds with Exposed Bone, Tendon, Muscle, Joint, and Hardware
|
View HTML
|
| Toggle Summary
|
Grafix® Cost Comparative Manuscript Reporting Wound Care Cost Reduction is Available Electronically in a Peer-Reviewed Journal
|
View HTML
|
| Toggle Summary
|
Osiris to Present Clinical and Scientific Studies at Desert Foot 2016
Experts to host a variety of presentations at Desert Foot Conference, October 19 - 22, 2016, in Phoenix, Arizona
|
View HTML
|
| Toggle Summary
|
Net Health and Osiris Therapeutics Announce the Broad Availability of Grafix® to Wound Care Patients Due to WoundExpert® EMR Integration
|
View HTML
|
| Toggle Summary
|
Osiris Therapeutics Announces Appointment of Alberto Avendano, M.D. as Chief Medical Officer
|
View HTML
|
| Toggle Summary
|
Osiris to Present Clinical and Scientific Studies at Symposium on Advanced Wound Care (SAWC)
Experts to host a variety of presentations at Symposium on Advanced Wound Care, October 07 - 09, 2016, in Las Vegas, Nevada
|
View HTML
|
| Toggle Summary
|
Osiris Therapeutics to Present at 2016 Cell & Gene Meeting on the Mesa
|
View HTML
|
